Dialysis low-volume threshold doubles to 8,000 treatments
Jul 27, 2026 – Nov 16, 2026
-
CMS proposes 2027 dialysis payment rate above $299 for first time
The proposed CY2027 ESRD PPS rule would raise the per-treatment base rate to $299.55, a projected 1.1 percent overall payment increase, while retiring the Hypercalcemia quality measure and adding a new post-TDAPA drug payment category.
Read this issue → -
Comment window closes on Medicare's 2027 dialysis payment rate, phosphate binder cost revealed
CMS's CY2027 ESRD PPS proposed rule would raise the per treatment dialysis base rate to $299.55, of which $15.96 reflects folding phosphate binder drug costs into the bundled payment for the first time, with the public comment period closing August 24, 2026.
Read this issue → -
2027 dialysis payment rate finalized
CMS set the 2027 ESRD base rate at $297.52 per treatment, up $15.81, with $12.85 of that from folding in phosphate binders, and doubled the low-volume threshold to 8,000 treatments with six tiers.
Read this issue → -
Dialysis low-volume threshold doubles to 8,000 treatments
CMS's final 2027 ESRD rule raises the low-volume payment adjustment threshold from 4,000 to 8,000 treatments, expands it to six tiers, and funds it with a roughly 1.1 percent budget-neutral cut to the base rate.
Read this issue →